
REXN Market Capitalization Overview
Market Cap: $323.73M as of Apr 2, 2026
$323.73M
$30.64M (10.45%)past month
As of Apr 2, 2026, REXN has a market capitalization of $323.73M. Over the past 30 days, its market cap has increased by 11.75%, while in the last 12 months, it has increased by 133.54%.
Market capitalization represents the total value of Rexahn Pharmaceuticals Inc. as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
REXN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of REXNhelps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Rexahn Pharmaceuticals Inc. as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
REXN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of REXNhelps investors assess the company's size and compare it with competitors for better investment decisions.
REXN Market Cap & Key Trends
See Rexahn Pharmaceuticals Inc.’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in REXN
Order type
Buy in
Order amount
Est. shares
0 shares
REXN Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $137.93M | +7.59% |
| Nov 3, 2025 | $128.21M | +18.89% |
| Oct 1, 2025 | $107.84M | +46.34% |
| Sep 2, 2025 | $73.69M | +15.43% |
| Aug 1, 2025 | $63.84M | +13.84% |
| Jul 1, 2025 | $56.08M | -13.77% |
| Jun 2, 2025 | $65.04M | +46.93% |
| May 1, 2025 | $44.26M | +11.07% |
| Apr 1, 2025 | $39.85M | +29.89% |
| Mar 3, 2025 | $30.68M | -10.02% |
| Feb 3, 2025 | $34.10M | -14.29% |
| Jan 2, 2025 | $39.78M | +9.57% |
REXN End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $323.73M | +133.54% |
| 2025 | $138.62M | +268.99% |
| 2024 | $37.57M | -44.87% |
| 2023 | $68.14M | -7.23% |
| 2022 | $73.45M | +13.82% |
| 2021 | $64.54M | — |
FAQs About Rexahn Pharmaceuticals Inc. (REXN) Market Cap
As of Apr 2, 2026, the market capitalization of REXN is $323.73M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Rexahn Pharmaceuticals Inc.’s market capitalization has increased by 10.45%, changing from $293.10M to $323.73M as of Apr 2, 2026.
In the last 3 months, Rexahn Pharmaceuticals Inc.’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Rexahn Pharmaceuticals Inc.’s market capitalization increased from $37.57M in January to $138.62M in December, reflecting a 268.99% change.
In the past five years, REXN has had a compound annual growth rate (CAGR) of 16.52% in market capitalization. This means its market cap has grown at an average rate of 16.52% per year.